Amy Bachrodt

SVP, Finance

Amy Bachrodt (SVP, Finance) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Maze Therapeutics, Inc. (MAZE). The largest single filing was $581K of MAZE (14,400 sh across 2 lots, as filed), executed Dec 29 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 5 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.3M

shares × price, as filed

Last traded

Mar 2

Filed Mar 3

Median ADV $16.9M across their filed names

Open performance→

Volume by month

Buys $0 Sells $1.3M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 5 filings

Sector per market data · by filing · past 12 months

Most traded names

MAZE

Maze Therapeutics, Inc. MAZE · 0 buys · 5 sells 5 filings

Recent filings

MAZESALE Maze Therapeutics, Inc. View filing → $168K
3,700 sh × $45.47
Exec Mar 2
Filed Mar 3 · 5:30 PM ET MAZESALE Maze Therapeutics, Inc. View filing → $187K
4,064 sh × $46.03
Exec Feb 2
Filed Feb 4 · 5:30 PM ET MAZESALE Maze Therapeutics, Inc. View filing → $228K
5,000 sh × $45.52
Exec Jan 22
Filed Jan 26 · 5:30 PM ET MAZESALE Maze Therapeutics, Inc. View filing → $103K
2,595 sh × $39.57
Exec Jan 2
Filed Jan 6 · 5:30 PM ET MAZESALE Maze Therapeutics, Inc. View filing → $581K
14,400 sh across 2 lots
Exec Dec 29 2025
Filed Dec 31 2025 · 5:30 PM ET